Your browser doesn't support javascript.
loading
Extracorporeal membrane oxygenation in Stenotrophomonas maltophilia pneumonia during acute myeloid leukemia: A case report.
Saito, Kenki; Aokage, Toshiyuki; Sato, Takayuki; Tsukahara, Kohei; Tokioka, Fumiaki; Otake, Takanao; Irie, Hiromasa; Ueda, Yasunori.
Afiliación
  • Saito K; Department of Hematology/Oncology, Kurashiki Central Hospital, Japan.
  • Aokage T; Department of Geriatric Emergency Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Sato T; Department of Hematology/Oncology, Kurashiki Central Hospital, Japan.
  • Tsukahara K; Department of Emergency, Critical Care and Disaster Medicine, Okayama University Hospital, Okayama, Japan.
  • Tokioka F; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Otake T; Department of Anesthesiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Irie H; Department of Anesthesiology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ueda Y; Department of Hematology/Oncology, Kurashiki Central Hospital, Japan.
Respir Med Case Rep ; 31: 101224, 2020.
Article en En | MEDLINE | ID: mdl-32995263
ABSTRACT
Stenotrophomonas maltophilia (S. maltophilia) is a Gram-negative, multidrug-resistant organism that both opportunistically infects the bloodstream and leads to pneumonia in immunosuppressed patients, including those with hematologic malignancies. In patients with severe respiratory failure, venovenous extracorporeal membrane oxygenation (VV ECMO) can stabilize the respiratory status. However, whether ECMO in patients with hematologic malignancies improves the clinical outcomes is still controversial because ECMO increases the risk of the exacerbation of sepsis and bleeding. We report a case of a 46-year-old man with Stenotrophomonas maltophilia hemorrhagic pneumonia acquired during consolidation chemotherapy for acute myeloid leukemia in whom VV ECMO lead to a good clinical outcome. The stabilization of his respiratory status achieved with VV ECMO allowed time for trimethoprim-sulfamethoxazole antibiotic therapy to improve the pneumonia. We suggest the background of patients, including comorbidities and general conditions, should be taken into account when considering the clinical indications of ECMO.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Respir Med Case Rep Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Respir Med Case Rep Año: 2020 Tipo del documento: Article País de afiliación: Japón